enCore Energy Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EU research report →
Range $1.44 – $3.75
Price Chart
About the company
enCore Energy Corp. is a U. S.
- CEO
- Richard H. Little
- IPO
- 2011
- Employees
- 168
- HQ
- Dallas, TX, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a deep downtrend, trading well below its 200-day average of 1.8265 and far under the 52-week high of 4.18. The setup is still a damaged base near the lower end of the yearly range, with only a modest rebound from the 52-week low of 0.77.
Street sentiment is constructive but cautious: consensus is Buy, with an average target around 2.9 versus a 1.03 share price. Recent action has been mixed, with Jefferies initiating at Buy while H.C. Wainwright trimmed its target to 3.50 from 3.75.
The earnings profile is still weak, with 0/7 recent quarters beating estimates and the last reported quarter missing by 40.0%. Next-year EPS is still expected to stay negative at -0.229, so shareholders should watch for any improvement in loss size and execution on uranium output.
The pattern is net buying, led by meaningful open-market purchases from the Executive Chairman and CEO. Several August awards and exempt transactions look like compensation-related noise, but the discretionary P buys from senior leadership are the clearer signal.
Profitability remains under pressure, with gross margin at -42.1%, ROE at -26.26%, and ROA at -13.67%. Revenue growth is positive at 328.4% year over year, but cash flow is still negative, with -24.99 million in operating cash flow and -4.995 million in free cash flow.
EU sits in the higher-risk end of the uranium group: the market is pricing a turnaround before the fundamentals fully show it. On valuation, the shares trade at a negative P/E of -3.19, which leaves the story more dependent on execution than current earnings power.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $207.82M
- P/E
- -3.27
- Fwd P/E
- 21.83
- PEG
- 0.02
- P/S
- 3.82
- P/B
- 0.94
- EV/EBITDA
- -4.38
- Div Yield
- 0.00%
- Gross Margin
- 5.77%
- Op Margin
- -153.41%
- Net Margin
- -112.48%
- ROE
- -25.71%
- ROIC
- -20.57%
Latest fiscal year · YoY change
- Revenue
- $59.21M+1.5%
- Gross Profit
- $13.30M+284.5%
- Op Income
- $-90,239,501
- Net Income
- $-78,013,823-27.1%
- EPS
- $-0.41-20.6%
- OCF Growth
- +44.7%
- FCF Growth
- +20.4%
- 52W High
- $4.18
- 52W Low
- $0.77
- 50D MA
- $1.16
- 200D MA
- $1.83
- Beta
- 1.25
- RSI (14)
- 46
- Avg Volume
- 4.97M
No earnings-call transcripts are available for EU yet.
- Free Float
- 98.3%
- Shares Outstanding
- 194.22M
- Float Shares
- 190.98M
of shares held by institutions
169 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Van Eck Associates Corp | 15.16M | ▲ 1.19M |
| Mirae Asset Global Etfs Holdings Ltd. | 13.26M | ▲ 171.70K |
| Blackrock, Inc. | 11.37M | ▲ 996.05K |
| Vanguard Capital Management LLC | 6.10M | ▲ 6.10M |
| Azarias Capital Management, L.P. | 4.09M | ▼ 975.81K |
| Vident Advisory, LLC | 3.88M | ▲ 366.06K |
| State Street Corp | 3.39M | ▲ 18.58K |
| Geode Capital Management, LLC | 2.81M | ▲ 406.94K |
| Ubs Group AG | 2.67M | ▲ 57.75K |
| Morgan Stanley | 2.41M | ▼ 1.82M |
| Defiance Etfs, LLC | 2.11M | ▲ 2.11M |
| Toroso Investments, LLC | 2.10M | ▲ 2.10M |
Held by 89 ETFs
Biggest fund positions in EU by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Hudson Robert W. | other | 60,000 |
| Oct 1, 26 | Hudson Robert W. | other | 14,610 |
| Oct 1, 26 | Hudson Robert W. | other | 60,000 |
| Oct 1, 26 | Kremke Kevin L | other | 62,500 |
| Oct 1, 26 | Kremke Kevin L | other | 62,500 |
| Oct 1, 26 | Kremke Kevin L | other | 15,219 |
| Sep 24, 26 | McCoig Dain A | other | 25,000 |
| Sep 24, 26 | McCoig Dain A | other | 25,000 |
| Sep 24, 26 | McCoig Dain A | other | 6,088 |
| Sep 21, 26 | Little Richard H | buy | 10,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EU coverage
Recent articles, reports, and earnings notes.

Texas Rich, Revealed: Every Stock Gerardo Del Real Is Teasing in Junior Resource Monthly
Gerardo Del Real’s Digest Publishing “Texas Rich” promotion sells Junior Resource Monthly and teases three nuclear-energy stocks. We follow the clues to the basket.

Trump Nuclear Mega-BOOM, Revealed: Every Stock Marc Lichtenfeld Is Teasing in The Oxford Income Letter
Marc Lichtenfeld of The Oxford Club is pitching the “Trump Nuclear Mega-BOOM” and Uranium Profit Package. We trace the clues to its three-stock nuclear basket and test the hype against filings.

Uranium Profit Package, Revealed: Every Stock Marc Lichtenfeld Is Teasing in The Oxford Income Letter
Marc Lichtenfeld’s Uranium Profit Package from The Oxford Club’s The Oxford Income Letter links an AI energy crunch to uranium, SMRs and nuclear-power stocks.
Want a deeper read on EU?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
enCore Energy Completes Distribution of Verdera Common Shares to its Shareholders
prnewswire.com · Oct 1
Gentoo Media Inc. agrees EUR 50 million senior secured loan and secures full underwriting commitments for a planned EUR 50 million share issue to refinance its December 2026 bonds
gurufocus.com · Oct 1
Notice to attend an Extraordinary General Meeting of Sivers Semiconductors AB
gurufocus.com · Sep 29
enCore Energy Corp. (NASDAQ:EU) Stock Has Consensus Price Target of $2.90 According to Analysts
defenseworld.net · Sep 28
Richard Little Purchases 10,000 Shares of enCore Energy (NASDAQ:EU) Stock
defenseworld.net · Sep 24
enCore Energy Engages North Star Investor Relations and Provides Update on Distribution of Verdera Common Shares to its Shareholders
prnewswire.com · Sep 21
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
gurufocus.com · Sep 18
ACG METALS LIMITED ACG Delivers Material Uplift in Gediktepe NPV to US$1.2bn ACG Metals Limited
gurufocus.com · Sep 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed October 5, 2026 · Live quote · Not investment advice